Analyst James Terwilliger works at NORTHLAND CAPITAL and is focused on the Healthcare sector with 37 price targets and ratings documented since 2013 spanning on 4 stocks. Analyst's average stock valuation to be materialised ratio is 70.83% with an average time for price targets to be met of 415.25 days.
Most recent stock forecast was given on CSII, Cardiovascular Systems, Inc at 10-Nov-2021.
James Terwilliger best performing recommendations are on ZYXI.
The best stock recommendation documented was for ZYXI at 4/1/2020. The price target of $13.64 was fulfilled within 26 days with a profit of $3.82 (38.9%) receiving and performance score of 14.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
25
$10.28 (69.84%)
48
1 months 21 days ago
3/7 (42.86%)
$14.07 (49.95%)
549
Hold
18
$3.28 (22.28%)
32
7 months 27 days ago
2/4 (50%)
$3.46 (12.49%)
167
Buy
20
$5.28 (35.87%)
20
8 months 30 days ago
13/17 (76.47%)
$7.45 (27.03%)
351
Buy
34
$19.28 (130.98%)
34
10 months 6 days ago
1/5 (20%)
$14.64 (69.03%)
294
Buy
49
1 years 2 months 17 days ago
17/20 (85%)
$8.56 (31.84%)
408